The purpose of our study was to explore the effect of T2DM on the biological characteristics of breast cancer, and to investigate whether the difference of IGF-1R and Ki-67 expressions in breast cancer affects the prognosis of these patients with diabetes mellitus. Here, MKI67 is linked to breast cancer.